Acceptability of a Fixed Combination of Fenofibrate and Metformin
NCT ID: NCT00348725
Last Updated: 2007-09-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
69 participants
INTERVENTIONAL
2005-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
fenofibrate and metformin fixed combination (drug)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
20 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Solvay Pharmaceuticals
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Global Clinical Director Solvay
Role: STUDY_DIRECTOR
Solvay Pharmaceuticals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Site 24
Anzin, , France
Site 23
Bachant, , France
Site 21
Bauné, , France
Site 32
Bersée, , France
Site 34
Briollay, , France
Site 27
Denain, , France
Site 28
Denain, , France
Site 5
Le Temple-de-Bretagne, , France
Site 29
Nantes, , France
Site 2
Nantes, , France
Site 8
Nantes, , France
Site 9
Nantes, , France
Site 1
Nort-sur-Erdre, , France
Site 13
Parçay-les-Pins, , France
Site 26
Quarouble, , France
Site 7
Saint Aignan Le Grand, , France
Site 30
Saint-Amand, , France
Site 10
Saint-Étienne-de-Montluc, , France
Site 4
Saint-Herblain, , France
Site 11
Sautron, , France
Site 17
Segré, , France
Site 33
Thiant, , France
Site 12
Thouars, , France
Site 25
Vieux-Condé, , France
Site 20
Vihiers, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C LF23-0121 04 02
Identifier Type: -
Identifier Source: org_study_id